tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corey Davis, 41 are a BUY (83.67%), 8 are a HOLD (16.33%).
Analyst Corey Davis, carries an average stock price target met ratio of 66.5% that have a potential upside of 49.24% achieved within 337 days. Previously, Corey Davis worked at LIFESCI.
Corey Davis’s has documented 81 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZYNE, Zynerba Pharmaceuticals at 15-Aug-2023.
Analyst best performing recommendations are on ZYNE (ZYNERBA PHARMACEUTICALS).
The best stock recommendation documented was for ZYNE (ZYNERBA PHARMACEUTICALS) at 8/8/2017. The price target of $7 was fulfilled within 1 day with a profit of $0.73 (11.64%) receiving and performance score of 116.43.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 02-Mar-2022
$1
$0.86 (614.29%)
$2
3 years 9 months 20 days ago
(09-May-2022)
4/5 (80%)
$-0.2 (-16.67%)
77
Hold Since 28-Jun-2016
$2
$1.86 (1328.57%)
$4
3 years 9 months 20 days ago
(09-May-2022)
7/9 (77.78%)
$0.8 (66.67%)
151
Hold Since 02-Mar-2022
$1
$0.86 (614.29%)
$3
3 years 9 months 23 days ago
(06-May-2022)
8/18 (44.44%)
$-0.42 (-29.58%)
74
Buy Since 24-Apr-2020
$6
$5.86 (4185.71%)
$11
3 years 11 months 20 days ago
(09-Mar-2022)
1/4 (25%)
$3.53 (142.91%)
250
Hold Since 09-Jun-2017
4 years 3 months 24 days ago
(05-Nov-2021)
1/2 (50%)
$10.51 (91.47%)
83
What Year was the first public recommendation made by Corey Davis?
